24.02.2021 Brexit Webinar Effects of the free trade agreement on the MedTech sector

Zum Thema

After intensive negotiations of almost one year, finally an agreement has been reached on the future relationship be-tween Europe and the UK.

Among other things, the agreement on future relations with the UK creates a broad economic partnership, which is based on a free trade agreement without tariffs and quotas and thus averts any major trade barriers.

However, there will be regulatory / legal changes – also for the medtech industry, whose export quota is around 65 per-cent (almost 5 percent goes to the exporting country Great
Britain).

What does the successful conclusion of the negotiations now mean for the medtech industry? To support the industry, the Brexit webinar will provide information on the final agree-ment and what has been changed from 1 January 2021.

Among others the following questions will be addressed:

• Under what rules and until when is the new UKCA mark-ing needed to be applied?
• What is (legally) new with regard to UK notified bodies?
• What are the tasks and responsibilities of the UK responsible person?
• What does the transition period for registering medical devices under the MHRA look like?
• What (legal) changes can be expected with regard to the registration of medical devices in the UK?

The seminar is held in English!

Zielgruppe

The training course is aimed for all interested MedTech com-panies. The aim is to inform the industry about the final agreement between EU and UK and what has been changed from 1 January 2021.

Referenten

• Phil Brown
  Director, Regulatory & Compliance
  Association of British HealthTech Industries | London
  
• Jesús Rueda Rodríguez
  Director International Affairs
  MedTech Europe | Brussels
  

Moderation

• Clara Mailin Allonge
  Head of Department of SMEs and Economic Policy
  Federal Association of Medical Technology (BVMed) | Berlin
  

Programm

Teilnahmebedingungen